Free Trial
NASDAQ:IOBT

IO Biotech (IOBT) Stock Price, News & Analysis

IO Biotech logo
$1.50 +0.02 (+1.01%)
Closing price 03:54 PM Eastern
Extended Trading
$1.46 -0.04 (-2.99%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IO Biotech Stock (NASDAQ:IOBT)

Key Stats

Today's Range
$1.46
$1.52
50-Day Range
$0.92
$1.62
52-Week Range
$0.66
$1.73
Volume
182,872 shs
Average Volume
159,820 shs
Market Capitalization
$99.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.33
Consensus Rating
Buy

Company Overview

IO Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

IOBT MarketRank™: 

IO Biotech scored higher than 54% of companies evaluated by MarketBeat, and ranked 420th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IO Biotech has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    IO Biotech has only been the subject of 1 research reports in the past 90 days.

  • Read more about IO Biotech's stock forecast and price target.
  • Earnings Growth

    Earnings for IO Biotech are expected to grow in the coming year, from ($1.35) to ($1.32) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IO Biotech is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IO Biotech is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IO Biotech has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about IO Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    0.29% of the float of IO Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    IO Biotech has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IO Biotech has recently increased by 28.03%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    IO Biotech does not currently pay a dividend.

  • Dividend Growth

    IO Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.29% of the float of IO Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    IO Biotech has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IO Biotech has recently increased by 28.03%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for IO Biotech this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for IOBT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added IO Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IO Biotech insiders have bought more of their company's stock than they have sold. Specifically, they have bought $20,850.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 4.80% of the stock of IO Biotech is held by insiders.

  • Percentage Held by Institutions

    54.76% of the stock of IO Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about IO Biotech's insider trading history.
Receive IOBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter.

IOBT Stock News Headlines

IOBT IO Biotech, Inc. - Seeking Alpha
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

IOBT Stock Analysis - Frequently Asked Questions

IO Biotech's stock was trading at $0.92 on January 1st, 2025. Since then, IOBT shares have increased by 63.6% and is now trading at $1.5050.

IO Biotech, Inc. (NASDAQ:IOBT) released its earnings results on Tuesday, November, 12th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by $0.07.

IO Biotech (IOBT) raised $111 million in an IPO on Friday, November 5th 2021. The company issued 7,150,000 shares at $14.00-$17.00 per share.

Shares of IOBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IO Biotech investors own include COMPASS Pathways (CMPS), Nkarta (NKTX), PayPal (PYPL), AbCellera Biologics (ABCL), atai Life Sciences (ATAI), Meta Platforms (META) and

Company Calendar

Last Earnings
11/12/2024
Today
7/03/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IOBT
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.33
High Stock Price Target
$12.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+530.6%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$95.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
2.08

Miscellaneous

Free Float
62,719,000
Market Cap
$97.50 million
Optionable
Not Optionable
Beta
0.36
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:IOBT) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners